Home Cart Sign in  
Chemical Structure| 38953-85-4 Chemical Structure| 38953-85-4

Structure of Isovitexin
CAS No.: 38953-85-4

Chemical Structure| 38953-85-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isovitexin, a natural product isolated and purified from the seeds of Vitex trifolia L., exhibits a potential antioxidant activity, shows a strong antihyperglycemic action, and inhibits α-glucosidase in vivo.

Synonyms: Saponaretin; Homovitexin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Isovitexin

CAS No. :38953-85-4
Formula : C21H20O10
M.W : 432.38
SMILES Code : OC1=C(C2=O)C(OC(C3=CC=C(O)C=C3)=C2)=CC(O)=C1[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO
Synonyms :
Saponaretin; Homovitexin
MDL No. :MFCD00076044
InChI Key :MYXNWGACZJSMBT-VJXVFPJBSA-N
Pubchem ID :162350

Safety of Isovitexin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Isovitexin

MAPK
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat bone marrow mesenchymal stem cells (BMSCs) 150μmol/L To validate the restorative effects of Isovitexin on osteogenic differentiation, results showed that Isovitexin restored mitochondrial function and inhibited ferroptosis by upregulating SIRT3 expression. Bone Res. 2025 Jan 26;13(1):18
A549 cells 256 μg/ml 2 hours To determine whether isovitexin could block S. aureus internalization into the lung epithelial cells. Results showed that isovitexin significantly decreased the amount of intracellular S. aureus. J Microbiol Biotechnol. 2022 Oct 28;32(10):1284-1291
porcine ovarian granulosa cells (GCs) 40 mmol/L 12 hours Promoted the proliferation of porcine GCs and enhanced the enzyme activity of UCHL1. J Anim Sci Biotechnol. 2024 Jun 11;15(1):85
HuH7 cells 30 µM 72 hours Evaluate the effect on cholesterol biosynthesis, showing a reduction in cholesterol biosynthesis (-5.7%, not statistically significant) Antioxidants (Basel). 2021 Jun 29;10(7):1042
MC3T3-E1 cells 150 μmol/L 24 hours To investigate the effects of Isovitexin on glucocorticoid-induced oxidative stress and osteonecrosis, results showed that Isovitexin effectively regulated mitophagy, preserved mitochondrial homeostasis, suppressed ferroptosis, and restored osteogenic capacity by promoting SIRT3 expression. Bone Res. 2025 Jan 26;13(1):18
HPAECs (Human Pulmonary Artery Endothelial Cells) 25 or 50 μg/ml 24 hours Isovitexin inhibited LPS-induced IL-6 production in HPAECs. Int J Biol Sci. 2016 Jan 1;12(1):72-86
RAW 264.7 cells 25 or 50 μg/ml 24 hours Isovitexin significantly reduced LPS-induced pro-inflammatory cytokine secretion, iNOS and COX-2 expression, and decreased ROS generation. Int J Biol Sci. 2016 Jan 1;12(1):72-86

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SD rats Glucocorticoid-induced osteonecrosis of the femoral head model Intraperitoneal injection 15 mg/kg Every two days for 4 weeks To validate the preventive effects of Isovitexin on femoral head necrosis, results showed that Isovitexin significantly improved femoral head necrosis by upregulating SIRT3 expression and modulating mitophagy-mediated ferroptosis. Bone Res. 2025 Jan 26;13(1):18
Mice S. aureus pneumonia model Intraperitoneal injection 100 mg/kg Every 12 hours To evaluate the protective effect of isovitexin against S. aureus pneumonia. Results showed that isovitexin significantly improved the survival rate of infected mice, reduced the bacterial load in lung tissues, and alleviated pathological injury and inflammation in lung tissues. J Microbiol Biotechnol. 2022 Oct 28;32(10):1284-1291
Sprague-Dawley rats Acute gouty arthritis model Intraperitoneal injection 100 mg/kg Once daily for 1 week Isovitexin significantly reduced the ankle joint swelling index, alleviated inflammatory cell infiltration, ameliorated synovial cell proliferation, decreased levels of TNF-α, IL-1β, and IL-6, and remarkably decreased the expression of TLR4, MyD88, and p-NF-κB-p65 Pharm Biol. 2021 Dec;59(1):1326-1333
BALB/c mice LPS-induced acute lung injury model Intraperitoneal injection 50 or 100 mg/kg Single dose, lasting 12 hours Isovitexin pretreatment attenuated histopathological changes, infiltration of polymorphonuclear granulocytes and endothelial activation, decreased the expression of ICAM-1 and VCAM-1, reduced the levels of MPO and MDA, and increased the content of GSH and SOD in ALI. Int J Biol Sci. 2016 Jan 1;12(1):72-86

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.31mL

0.46mL

0.23mL

11.56mL

2.31mL

1.16mL

23.13mL

4.63mL

2.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories